Minot De Blois Advisors LLC Astrazeneca PLC Transaction History
Minot De Blois Advisors LLC
- $110 Billion
- Q3 2025
A detailed history of Minot De Blois Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Minot De Blois Advisors LLC holds 75 shares of AZN stock, worth $6,705. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$6,705
Previous $5.24 Million
9.79%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,521Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...